Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Vaccines"" wg kryterium: Temat


Tytuł :
Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy.
Autorzy :
Pathirana J; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: .
Kwatra G; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Maposa I; Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Groome MJ; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Madhi SA; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4793-4799. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cytomegalovirus Infections*/prevention & control
Diphtheria*
Diphtheria-Tetanus-acellular Pertussis Vaccines*
Haemophilus Vaccines*
Tetanus*
Antibodies, Bacterial ; Child ; Diphtheria-Tetanus-Pertussis Vaccine ; Hepatitis B Vaccines ; Humans ; Immunity, Humoral ; Infant ; Infant, Newborn ; Poliovirus Vaccine, Inactivated ; Vaccines, Combined ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: preliminary results.
Autorzy :
Zee JST; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong.; Infection Control Team, Hong Kong Sanatorium and Hospital, Hong Kong.
Lai KTW; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong.
Ho MKS; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong.
Leung ACP; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong.
Chan QWL; Infection Control Team, Hong Kong Sanatorium and Hospital, Hong Kong.
Ma ESK; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong.
Lee KH; Hospital Administration, Hong Kong Sanatorium and Hospital, Hong Kong.
Lau CC; Hospital Administration, Hong Kong Sanatorium and Hospital, Hong Kong.
Yung RWH; Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong.; Infection Control Team, Hong Kong Sanatorium and Hospital, Hong Kong.; Hospital Administration, Hong Kong Sanatorium and Hospital, Hong Kong.
Pokaż więcej
Źródło :
Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2021 Aug; Vol. 27 (4), pp. 312-313. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Comparative Study; Letter
MeSH Terms :
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
Immunogenicity, Vaccine*
COVID-19/*prevention & control
Health Personnel/*statistics & numerical data
Adult ; Antibodies, Neutralizing/blood ; COVID-19/epidemiology ; Female ; Hong Kong/epidemiology ; Humans ; Immunoglobulin G/blood ; Male ; Middle Aged ; SARS-CoV-2 ; Serologic Tests/methods ; Serologic Tests/statistics & numerical data ; Spike Glycoprotein, Coronavirus/immunology ; Vaccines, Inactivated/administration & dosage ; Vaccines, Inactivated/immunology ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/immunology
Raport
Tytuł :
Development and characterization of a plant-derived rotavirus-like particle vaccine.
Autorzy :
Kurokawa N; Mitsubishi Tanabe Pharma Corporation, 17-10, Nihonbashi-Koamicho, Chuo-ku, Tokyo 103-8405, Japan. Electronic address: .
Lavoie PO; Medicago Inc., 1020 route de l'Église office 600, Québec, QC, Canada.
D'Aoust MA; Medicago Inc., 1020 route de l'Église office 600, Québec, QC, Canada.
Couture MM; Medicago Inc., 1020 route de l'Église office 600, Québec, QC, Canada.
Dargis M; Medicago Inc., 1020 route de l'Église office 600, Québec, QC, Canada.
Trépanier S; Medicago Inc., 1020 route de l'Église office 600, Québec, QC, Canada.
Hoshino S; Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan.
Koike T; Mitsubishi Tanabe Pharma Corporation, Shonan Health Innovation Park, 2-26-1, Muraoka-Higashi, Fujisawa, Kanagawa 251-8555, Japan.
Arai M; Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan.
Tsutsui N; Mitsubishi Tanabe Pharma Corporation, 17-10, Nihonbashi-Koamicho, Chuo-ku, Tokyo 103-8405, Japan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 16; Vol. 39 (35), pp. 4979-4987. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Rotavirus*/genetics
Rotavirus Infections*/prevention & control
Rotavirus Vaccines*
Vaccines, Virus-Like Particle*/genetics
Animals ; Antibodies, Viral ; Rabbits ; Rats ; Vaccines, Attenuated
Czasopismo naukowe
Tytuł :
Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador.
Autorzy :
Elas M; National Center for Pharmacovigilance, Ministry of Health, San Salvador, El Salvador; Master's and Graduate School, Faculty of Medicine, University of El Salvador, San Salvador, El Salvador. Electronic address: .
Villatoro N; National Vaccination and Inmunization Program, Ministry of Health, San Salvador, El Salvador. Electronic address: .
Pezzoli L; Independent Consultant, Geneva, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4849-4855. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Haemophilus Vaccines*/adverse effects
Pharmaceutical Preparations*
Diphtheria-Tetanus-Pertussis Vaccine/adverse effects ; El Salvador ; Hepatitis B Vaccines/adverse effects ; Humans ; Infant ; Poliovirus Vaccine, Inactivated ; Vaccines, Combined/adverse effects
Czasopismo naukowe
Tytuł :
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
Autorzy :
Gooch KE; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Smith TRF; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA.
Salguero FJ; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Fotheringham SA; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Watson RJ; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Dennis MJ; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Handley A; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Humphries HE; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Longet S; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Tipton T; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Sarfas C; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Sibley L; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Slack GS; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Rayner E; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Ryan KA; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Schultheis K; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA.
Ramos SJ; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA.
White A; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Charlton S; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Sharpe SA; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Gleeson F; Department of Oncology, Oxford University, Oxford, UK.
Humeau LM; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA.
Hall Y; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Broderick KE; Inovio Pharmaceuticals, Plymouth Meeting, PA 19462, USA.
Carroll MW; Public Health England (PHE), Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom; Wellcome Centre for Human Genetics, Nuffield Dept of Medicine, Oxford University, OX3 7BN, UK.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4885-4894. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*
Vaccines, DNA*
Viral Vaccines*
Animals ; Antibodies, Neutralizing ; Antibodies, Viral ; COVID-19 Vaccines ; Humans ; Macaca mulatta ; Pandemics ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus
Czasopismo naukowe
Tytuł :
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
Autorzy :
Guilfoyle K; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK; Viroclinics Xplore, Nistelrooise Baan 3, 5374 Schaijk, The Netherlands(1).
Major D; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK.
Skeldon S; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK.
James H; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK.
Tingstedt JL; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
Polacek C; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
Lassauniére R; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
Engelhardt OG; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG Hertfordshire, UK. Electronic address: .
Fomsgaard A; Virus Research and Development Laboratory, Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark; Infectious Disease Research Unit, Clinical Institute, University of Southern Denmark, Sdr. Boulevard 29, DK-5000 Odense C, Denmark.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 09; Vol. 39 (34), pp. 4903-4913. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza A Virus, H5N1 Subtype*
Influenza Vaccines*
Influenza, Human*
Orthomyxoviridae Infections*/prevention & control
Vaccines, DNA*
Animals ; Antibodies, Viral ; Ferrets ; Humans ; Influenza A Virus, H3N2 Subtype ; Vaccines, Combined
Czasopismo naukowe
Tytuł :
Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States.
Autorzy :
Boikos C; Seqirus Inc., Kirkland, Quebec, Canada.
Fischer L; Veradigm, San Francisco, California, USA.
O'Brien D; Veradigm, San Francisco, California, USA.
Vasey J; Veradigm, San Francisco, California, USA.
Sylvester GC; Seqirus USA Inc., Summit, New Jersey, USA.
Mansi JA; Seqirus Inc., Kirkland, Quebec, Canada.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 02; Vol. 73 (3), pp. e692-e698.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza Vaccines*
Influenza, Human*/prevention & control
Adolescent ; Child ; Child, Preschool ; Humans ; Retrospective Studies ; Seasons ; United States/epidemiology ; Vaccines, Combined ; Vaccines, Inactivated
Czasopismo naukowe
Tytuł :
Immunogenicity and efficacy of a bivalent vaccine against infectious bronchitis virus.
Autorzy :
Abdel-Sabour MA; Department of Poultry Viral Vaccines, Veterinary Serum and Vaccine Research Institute (VSVRI), Agriculture Research Centre (ARC), Cairo, 11381, Egypt.
Rohaim MA; Department of Virology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt.
Salman OJA; Department of Poultry Viral Vaccines, Veterinary Serum and Vaccine Research Institute (VSVRI), Agriculture Research Centre (ARC), Cairo, 11381, Egypt.
Abodalal SE; Department of Poultry Viral Vaccines, Veterinary Serum and Vaccine Research Institute (VSVRI), Agriculture Research Centre (ARC), Cairo, 11381, Egypt.
Mohammad FF; Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt.
Madkour MS; Department of Poultry Viral Vaccines, Veterinary Serum and Vaccine Research Institute (VSVRI), Agriculture Research Centre (ARC), Cairo, 11381, Egypt.
Abdel-Wanis NA; Department of Poultry Viral Vaccines, Veterinary Serum and Vaccine Research Institute (VSVRI), Agriculture Research Centre (ARC), Cairo, 11381, Egypt.
Munir M; Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YG, UK. Electronic address: .
Pokaż więcej
Źródło :
Comparative immunology, microbiology and infectious diseases [Comp Immunol Microbiol Infect Dis] 2021 Aug; Vol. 77, pp. 101670. Date of Electronic Publication: 2021 May 10.
Typ publikacji :
Journal Article
MeSH Terms :
Coronavirus Infections*/prevention & control
Coronavirus Infections*/veterinary
Infectious bronchitis virus*
Poultry Diseases*/prevention & control
Viral Vaccines*
Animals ; Chickens ; Vaccines, Attenuated ; Vaccines, Combined
Czasopismo naukowe
Tytuł :
Covid 19 vaccination: Latest guidelines on blood donor deferral in India.
Autorzy :
Bhasker B; Department of Transfusion Medicine, Sparsh Hospital, Yeshwantpur, Bangalore. Electronic address: .
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Aug; Vol. 28 (3), pp. 299. Date of Electronic Publication: 2021 May 28.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
COVID-19 Vaccines*/administration & dosage
Practice Guidelines as Topic*
SARS-CoV-2*
Blood Banks/*standards
Blood Safety/*standards
COVID-19/*prevention & control
Donor Selection/*standards
Adolescent ; Adult ; COVID-19/epidemiology ; COVID-19/transmission ; Female ; Humans ; Immunization Programs ; Immunization Schedule ; Immunization, Secondary ; India ; Male ; Middle Aged ; Time Factors ; Vaccination ; Vaccination Coverage ; Vaccines, Attenuated ; Vaccines, Inactivated ; Young Adult
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study.
Autorzy :
Wang J; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China; CHESS-COVID-19 Group, Jincheng People's Hospital, Jincheng, China; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
Hou Z; CHESS-COVID-19 Group, Jincheng People's Hospital, Jincheng, China.
Liu J; CHESS-COVID-19 Group, Jinzhou Central Hospital, Jinzhou, China.
Gu Y; CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang City, Shenyang China.
Wu Y; CHESS-COVID-19 Group, Hospital of Chengdu Office, People's Government of Tibet Autonomous Region, Chengdu, China.
Chen Z; CHESS-COVID-19 Group, Baoding People's Hospital, Baoding, China.
Ji J; CHESS-COVID-19 Group, Lishui Central Hospital, Lishui, China.
Diao S; CHESS-COVID-19 Group, The Third People's Hospital of Linfen City, Linfen, China.
Qiu Y; CHESS-COVID-19 Group, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China.
Zou S; CHESS-COVID-19 Group, The Third People's Hospital of Zhenjiang City, Zhenjiang, China.
Zhang A; CHESS-COVID-19 Group, Jincheng People's Hospital, Jincheng, China.
Zhang N; CHESS-COVID-19 Group, Jincheng People's Hospital, Jincheng, China.
Wang F; CHESS-COVID-19 Group, Jinzhou Central Hospital, Jinzhou, China.
Li X; CHESS-COVID-19 Group, Jinzhou Central Hospital, Jinzhou, China.
Wang Y; CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang City, Shenyang China.
Liu X; CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang City, Shenyang China.
Lv C; CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang City, Shenyang China.
Chen S; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
Liu D; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
Ji X; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
Liu C; CHESS-COVID-19 Group, Hospital of Chengdu Office, People's Government of Tibet Autonomous Region, Chengdu, China.
Ren T; CHESS-COVID-19 Group, Hospital of Chengdu Office, People's Government of Tibet Autonomous Region, Chengdu, China.
Sun J; CHESS-COVID-19 Group, Baoding People's Hospital, Baoding, China.
Zhao Z; CHESS-COVID-19 Group, Lishui Central Hospital, Lishui, China.
Wu F; CHESS-COVID-19 Group, Lishui Central Hospital, Lishui, China.
Li F; CHESS-COVID-19 Group, The Third People's Hospital of Linfen City, Linfen, China.
Wang R; CHESS-COVID-19 Group, The Third People's Hospital of Linfen City, Linfen, China.
Yan Y; CHESS-COVID-19 Group, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China.
Zhang S; CHESS-COVID-19 Group, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China.
Ge G; CHESS-COVID-19 Group, The Third People's Hospital of Zhenjiang City, Zhenjiang, China.
Shao J; CHESS-COVID-19 Group, The Third People's Hospital of Zhenjiang City, Zhenjiang, China.
Yang S; Department of Hepatology, The First Hospital of Lanzhou University, Lanzhou, China.
Liu C; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Huang Y; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Xu D; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Li X; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
Ai J; Department of Infectious Disease, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
He Q; National Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen, Shenzhen, China.
Zheng MH; NAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhang L; Department of Hepatology, The First Hospital of Lanzhou University, Lanzhou, China.
Xie Q; Department of Infectious Disease, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Rockey DC; Digestive Disease Research Center, Medical University South Carolina, Charleston, South Carolina, USA.
Fallowfield JA; Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Zhang W; Department of Infectious Disease, Huashan Hospital Affiliated to Fudan University, Shanghai, China. Electronic address: .
Qi X; CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of hepatology [J Hepatol] 2021 Aug; Vol. 75 (2), pp. 439-441. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Vaccination*/adverse effects
Vaccination*/methods
Vaccination*/statistics & numerical data
Vaccines, Inactivated*/administration & dosage
Vaccines, Inactivated*/adverse effects
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Immunogenicity, Vaccine/*immunology
Adult ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/adverse effects ; China/epidemiology ; Female ; Humans ; Male ; Outcome Assessment, Health Care ; SARS-CoV-2/immunology
Czasopismo naukowe
Tytuł :
Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
Autorzy :
Sattler C; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Hoffmann P; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany; Regensburg Center for Interventional Immunology (RCI), Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Herzberg PY; Faculty of Humanities and Social Sciences, Personality Psychology and Psychological Assessment, Helmut Schmidt University Hamburg, Holstenhofweg 85, 22043 Hamburg, Germany.
Weber D; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Holler B; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Fehn U; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany; Regensburg Center for Interventional Immunology (RCI), Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Plentz A; Dept. of Medical Microbiology and Hygiene, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Beckhove P; Regensburg Center for Interventional Immunology (RCI), Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Winkler J; Dept. of Medicine 5 - Hematology and Oncology, University Hospital Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.
Edinger M; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany; Regensburg Center for Interventional Immunology (RCI), Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Herr W; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Holler E; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany.
Wolff D; Dept. of Internal Medicine III, University Hospital Regensburg, Franz-Joseph-Strauss-Allee 11, 93053 Regensburg, Germany. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 30; Vol. 39 (33), pp. 4742-4750. Date of Electronic Publication: 2021 May 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diphtheria*
Haemophilus Vaccines*
Hematopoietic Stem Cell Transplantation*
Adult ; Antibodies, Bacterial ; Diphtheria-Tetanus-Pertussis Vaccine ; Humans ; Infant ; Poliovirus Vaccine, Inactivated ; Retrospective Studies ; Vaccination ; Vaccines, Combined ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis.
Autorzy :
Furuya-Kanamori L; UQ Centre for Clinical Research, The University of Queensland, Herston, Australia. Electronic address: .
Xu C; Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Doi SAR; Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Clark J; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia.
Wangdi K; Research School of Population Health, Australian National University, Canberra, Australia.
Mills DJ; Research School of Population Health, Australian National University, Canberra, Australia; Dr Deb The Travel Doctor, Travel Medicine Alliance, Brisbane, Australia.
Lau CL; Research School of Population Health, Australian National University, Canberra, Australia; Dr Deb The Travel Doctor, Travel Medicine Alliance, Brisbane, Australia; School of Public Health, The University of Queensland, Herston, Australia.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 22; Vol. 39 (32), pp. 4429-4436. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Encephalitis Virus, Japanese*
Encephalitis, Japanese*/prevention & control
Japanese Encephalitis Vaccines*/adverse effects
Animals ; Antibodies, Viral ; Mice ; Network Meta-Analysis ; Vaccination ; Vaccines, Attenuated/adverse effects ; Vaccines, Inactivated/adverse effects
Czasopismo naukowe
Tytuł :
Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana.
Autorzy :
Congdon M; Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hong H; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Young RR; Division of Pediatric Infectious Diseases, Duke University, Durham, North Carolina, USA.
Cunningham CK; Division of Pediatric Infectious Diseases, Duke University, Durham, North Carolina, USA.
Enane LA; The Ryan White Center for Pediatric Infectious Disease and Global Health, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Arscott-Mills T; Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Botswana-UPenn Partnership, Gaborone, Botswana.; Department of Pediatrics and Adolescent Health, University of Botswana, Gaborone, Botswana.
Banda FM; Botswana-UPenn Partnership, Gaborone, Botswana.; Department of Pediatrics and Adolescent Health, University of Botswana, Gaborone, Botswana.
Chise M; Ministry of Health, Gaborone, Botswana.
Motlhatlhedi K; Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana.
Feemster K; Division of Pediatric Infectious Diseases and Global Health Center, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Patel SM; Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University, Durham, North Carolina, USA.
Boiditswe S; Botswana-UPenn Partnership, Gaborone, Botswana.
Leburu T; Botswana-UPenn Partnership, Gaborone, Botswana.
Shah SS; Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Medical Center, Cincinnati, Ohio, USA.
Steenhoff AP; Department of Pediatrics and Adolescent Health, University of Botswana, Gaborone, Botswana.; Division of Pediatric Infectious Diseases and Global Health Center, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kelly MS; Division of Pediatric Infectious Diseases, Duke University, Durham, North Carolina, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 15; Vol. 73 (2), pp. e410-e416.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Haemophilus Vaccines*
Haemophilus influenzae type b*
Pneumonia*/epidemiology
Pneumonia*/prevention & control
Pneumonia, Pneumococcal*/epidemiology
Pneumonia, Pneumococcal*/prevention & control
Botswana/epidemiology ; Child ; Hospitalization ; Humans ; Infant ; Pneumococcal Vaccines ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.
Autorzy :
Poland GA; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA. Electronic address: .
Ovsyannikova IG; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Kennedy RB; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 13; Vol. 39 (31), pp. 4239-4241. Date of Electronic Publication: 2021 Jun 14.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Viral Vaccines*
COVID-19 Vaccines ; Epitopes, B-Lymphocyte ; Epitopes, T-Lymphocyte ; Humans ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Vaccines, Subunit
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine:a phase I clinical trial.
Autorzy :
Wu ZW; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
Li QL; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China.
Zhou HS; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China.
Duan K; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China.
Gao Z; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
Zhang XJ; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China.
Jiang ZJ; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China.
Hao ZY; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China.
Jin F; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
Bai X; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China.
Li Q; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
Xu GL; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China.
Zhao YL; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China.
Yang XM; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2311-2318. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Rotavirus*
Rotavirus Infections*/prevention & control
Rotavirus Vaccines*/adverse effects
Adult ; Antibodies, Viral ; China ; Double-Blind Method ; Humans ; Immunogenicity, Vaccine ; Infant ; Vaccines, Attenuated/adverse effects ; Vaccines, Combined
Czasopismo naukowe
Tytuł :
Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial.
Autorzy :
Park J; Global Clinical Sciences, Sanofi Pasteur, Singapore, Singapore.
Archuleta S; Division of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Oh MH; Department of Medicine, Changi General Hospital, Singapore, Singapore.
Shek LP; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Wang H; Biostatistics, Sanofi, Beijing, China.
Bonaparte M; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, PA, USA.
Frago C; Global Clinical Sciences, Sanofi Pasteur, Singapore, Singapore.
Bouckenooghe A; Global Clinical Sciences, Sanofi Pasteur, Singapore, Singapore.
Jantet-Blaudez F; Research and External Innovation Department, Sanofi Pasteur, Marcy l'Etoile, France.
Begue S; Research and External Innovation Department, Sanofi Pasteur, Marcy l'Etoile, France.
Gimenez-Fourage S; Research and External Innovation Department, Sanofi Pasteur, Marcy l'Etoile, France.
Pagnon A; Research and External Innovation Department, Sanofi Pasteur, Marcy l'Etoile, France.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2107-2116. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Dengue*/prevention & control
Dengue Vaccines*/adverse effects
Dengue Virus*
Adolescent ; Adult ; Antibodies, Viral ; Child ; Follow-Up Studies ; Humans ; Immunogenicity, Vaccine ; Middle Aged ; Singapore ; Vaccines, Attenuated ; Vaccines, Combined ; Young Adult
Czasopismo naukowe
Tytuł :
Meningococcal vaccines in China.
Autorzy :
Xu Y; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Li Y; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Wang S; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Li M; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Xu M; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Ye Q; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2197-2204. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningitis, Meningococcal*/epidemiology
Meningitis, Meningococcal*/prevention & control
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis*
China/epidemiology ; Humans ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Vaxign2: the second generation of the first Web-based vaccine design program using reverse vaccinology and machine learning.
Autorzy :
Ong E; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Cooke MF; School of Information, University of Michigan, Ann Arbor, MI 48109, USA.; Undergraduate Research Opportunity Program, College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI 48109, USA.
Huffman A; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Xiang Z; Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Wong MU; Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Wang H; Department of Pathogenobiology, Daqing Branch of Harbin Medical University, Daqing, Helongjiang, China.
Seetharaman M; Undergraduate Research Opportunity Program, College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI 48109, USA.
Valdez N; Undergraduate Research Opportunity Program, College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI 48109, USA.
He Y; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2021 Jul 02; Vol. 49 (W1), pp. W671-W678.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Design*
Internet*
Machine Learning*
Software*
Vaccines*/chemistry
Vaccines*/immunology
Vaccinology/*methods
Antigens, Viral/chemistry ; Antigens, Viral/immunology ; COVID-19/virology ; COVID-19 Vaccines/chemistry ; COVID-19 Vaccines/immunology ; Epitopes/chemistry ; Epitopes/immunology ; Humans ; Proteome ; SARS-CoV-2/chemistry ; SARS-CoV-2/immunology ; SARS-CoV-2/metabolism ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology ; Workflow
Czasopismo naukowe
Tytuł :
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects.
Autorzy :
Pariente A; University Bordeaux, Inserm, BPH, U1219, Team Pharmacoepidemiology, 33000 Bordeaux, France; CHU de Bordeaux, pôle de santé publique, service de pharmacologie médicale, unité de pharmaco-épidémiologie et bon usage du médicament, 33000 Bordeaux, France. Electronic address: .
Bezin J; University Bordeaux, Inserm, BPH, U1219, Team Pharmacoepidemiology, 33000 Bordeaux, France; CHU de Bordeaux, pôle de santé publique, service de pharmacologie médicale, unité de pharmaco-épidémiologie et bon usage du médicament, 33000 Bordeaux, France.
Pokaż więcej
Źródło :
Therapie [Therapie] 2021 Jul-Aug; Vol. 76 (4), pp. 305-309. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Immunization Programs*
Pharmacoepidemiology*
COVID-19/*epidemiology
COVID-19/*prevention & control
COVID-19/immunology ; Europe/epidemiology ; Humans ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza Vaccines/adverse effects ; Influenza Vaccines/immunology ; SARS-CoV-2/immunology
Czasopismo naukowe
Tytuł :
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine.
Autorzy :
Moutsopoulos HM; Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens and Academy of Athens, Athens, Greece. Electronic address: .
Pokaż więcej
Źródło :
Journal of autoimmunity [J Autoimmun] 2021 Jul; Vol. 121, pp. 102649. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/immunology
COVID-19*/prevention & control
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/therapeutic use
Immunosuppression*
Rheumatic Diseases*/immunology
Rheumatic Diseases*/therapy
Vaccination*
SARS-CoV-2/*immunology
Cytokines/isolation & purification ; Humans ; Pneumococcal Vaccines/immunology ; Pneumococcal Vaccines/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies